156 related articles for article (PubMed ID: 21328056)
1. Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.
Singh A; Vastert SJ; Prakken BJ; Illges H
Rheumatol Int; 2012 Jun; 32(6):1581-7. PubMed ID: 21328056
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
Frémeaux-Bacchi V; Fischer E; Lecoanet-Henchoz S; Mani JC; Bonnefoy JY; Kazatchkine MD
Int Immunol; 1998 Oct; 10(10):1459-66. PubMed ID: 9796912
[TBL] [Abstract][Full Text] [Related]
3. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
Masilamani M; von Kempis J; Illges H
Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
[TBL] [Abstract][Full Text] [Related]
4. Plasma and synovial fluid soluble CD23 concentrations in children with juvenile chronic arthritis.
Kutukculer N; Caglayan S
Autoimmunity; 1998; 27(3):155-8. PubMed ID: 9609133
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis.
Massa M; Pignatti P; Oliveri M; De Amici M; De Benedetti F; Martini A
Clin Exp Rheumatol; 1998; 16(5):611-6. PubMed ID: 9779313
[TBL] [Abstract][Full Text] [Related]
6. Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis.
Masilamani M; Nowack R; Witte T; Schlesier M; Warnatz K; Glocker MO; Peter HH; Illges H
Scand J Immunol; 2004 Dec; 60(6):625-30. PubMed ID: 15584974
[TBL] [Abstract][Full Text] [Related]
7. Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.
Masilamani M; Rajasekaran N; Singh A; Low HZ; Albus K; Anders S; Behne F; Eiermann P; König K; Mindnich C; Ribarska T; Illges H
Rheumatol Int; 2008 Sep; 28(11):1137-41. PubMed ID: 18500464
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies.
Singh A; Blank M; Shoenfeld Y; Illges H
Rheumatol Int; 2008 May; 28(7):661-5. PubMed ID: 18172655
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD21 in sera and synovial fluid of arthritic patients.
Grottenthaler T; von Kempis J; Goldacker S; Illges H
Rheumatol Int; 2006 Jan; 26(3):240-3. PubMed ID: 15770483
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23.
Frémeaux-Bacchi V; Aubry JP; Bonnefoy JY; Kazatchkine MD; Kolb JP; Fischer EM
Eur J Immunol; 1998 Dec; 28(12):4268-74. PubMed ID: 9862364
[TBL] [Abstract][Full Text] [Related]
11. Relationship between reactive nitrogen intermediates and total immunoglobulin E, soluble CD21 and soluble CD23: comparison between cerebral malaria and nonsevere malaria.
Nacher M; Singhasivanon P; Kaewkungwal J; Silachamroon U; Treeprasertsuk S; Tosukhowong T; Vannaphan S; Looareesuwan S
Parasite Immunol; 2002 Aug; 24(8):395-9. PubMed ID: 12406193
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble CD21 in patients with systemic sclerosis.
Tomita M; Kadono T; Yazawa N; Kawashima T; Tamaki Z; Ashida R; Ohmatsu H; Asano Y; Sugaya M; Kubo M; Ihn H; Tamaki K; Sato S
Rheumatol Int; 2012 Feb; 32(2):317-21. PubMed ID: 21052675
[TBL] [Abstract][Full Text] [Related]
13. Detection of sCD21 in Human Blood Using ELISA is Influenced by Ethylenediaminetetraacetic Acid (EDTA) Containing Blood Collection Tubes.
Linke K; Illges H
Clin Lab; 2015; 61(11):1803-8. PubMed ID: 26732009
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation.
Masilamani M; Apell HJ; Illges H
J Immunol Methods; 2002 Dec; 270(1):11-8. PubMed ID: 12379334
[TBL] [Abstract][Full Text] [Related]
15. Origin and properties of soluble CD21 (CR2) in human blood.
Ling NR; Hardie DL; Johnson GD; MacLennan IC
Clin Exp Immunol; 1998 Sep; 113(3):360-6. PubMed ID: 9737663
[TBL] [Abstract][Full Text] [Related]
16. HLA antigens in juvenile arthritis. Pauciarticular and polyarticular juvenile arthritis are immunogenetically distinct.
Fernandez-Viña MA; Fink CW; Stastny P
Arthritis Rheum; 1990 Dec; 33(12):1787-94. PubMed ID: 2261000
[TBL] [Abstract][Full Text] [Related]
17. Comparative binding of soluble fragments (derCD23, sCD23, and exCD23) of recombinant human CD23 to CD21 (SCR 1-2) and native IgE, and their effect on IgE regulation.
Bowles SL; Jaeger C; Ferrara C; Fingeroth J; Van De Venter M; Oosthuizen V
Cell Immunol; 2011; 271(2):371-8. PubMed ID: 21889131
[TBL] [Abstract][Full Text] [Related]
18. The levels of soluble forms of CD21 and CD83 in multiple sclerosis.
Karampoor S; Zahednasab H; Etemadifar M; Keyvani H
J Neuroimmunol; 2018 Jul; 320():11-14. PubMed ID: 29759135
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of IgM-, IgA- and IgG-rheumatoid factors in seronegative polyarticular disease compared to pauciarticular disease in juvenile chronic arthritis as measured by ELISA.
Varbanova BB; Baleva M; Nikolov K; Mihailova D
Adv Exp Med Biol; 1999; 455():61-8. PubMed ID: 10599324
[TBL] [Abstract][Full Text] [Related]
20. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
